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ABSTRACT
Aims To establish how frequently different types of stakeholders were cited in the UKmedia debate about e-cigarette reg-
ulation, their stances towards different forms of e-cigarette regulation, and what rationales they employed in justifying
those stances.Methods Quantitative and qualitative content analyses of 104 articles about e-cigarette regulation pub-
lished in eight UK and three Scottish national newspapers between 1 January 2013 and 31 December 2014.
Results Reporting on e-cigarette regulation grew significantly (P< 0.001) throughout the sample period. Governments
and regulatory bodies were the most frequently cited stakeholders and uniformly supported regulation, while other stake-
holders did not always support regulation. Arguments for e-cigarette regulation greatly outnumbered arguments against
regulation. Regulating purchasing age, restricting marketing and regulating e-cigarettes as medicine were broadly
supported, while stakeholders disagreed about prohibiting e-cigarette use in enclosed public spaces. In rationalizing their
stances, supporters of regulation cited child protection and concerns about the safety of e-cigarette products, while oppo-
nents highlighted the potential of e-cigarettes in tobacco cessation and questioned the evidence base associating e-
cigarette use with health harms. Conclusions In the UK between 2013 and 2014, governments and tobacco control
advocates frequently commented on e-cigarettes in UK-wide and Scottish national newspapers. Almost all commentators
supported e-cigarette regulation, but there was disagreement about whether e-cigarette use should be allowed in enclosed
public spaces. This appeared to be linked to whether commentators emphasized the harms of vapour and concerns about
renormalizing smoking or emphasized the role of e-cigarettes as a smoking cessation aid.
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INTRODUCTION
Electronic cigarettes (e-cigarettes) have become increas-
ingly popular in recent years, [1,2] and are broadly consid-
ered to be less harmful than tobacco. However, the specific
risks of e-cigarette use and exposure are uncertain [3], and
e-cigarette regulation is hotly debated [4,5]. Some regard e-
cigarettes as useful tobacco cessation tools [6,7], but con-
cerns about negative impacts persist [8,9]. In addition to
direct harms, fears exist that e-cigarettes may reverse prog-
ress in de-normalizing smoking [10] and stimulate tobacco
use, particularly among young people [11].
In the United Kingdom, e-cigarette products containing
less than 20 mg of nicotine will be subject to various re-
strictions under the revised European Union Tobacco Prod-
ucts Directive (EU TPD) [12] from May 2016, while those
containing more than 20 mg, or making medical claims,
will need to be licensed as medicines by the Medicines
and Healthcare Products Regulatory Agency to be sold.
The Scottish Government, UK Department of Health and
Welsh Government intend to introduce age-of-sale restric-
tions and bans on proxy purchasing [13,14]. Additionally,
the Scottish Government plans to introduce restrictions on
domestic e-cigarette marketing, a register of e-cigarette
retailers, an age-verification policy, a requirement to for-
mally authorize under-18s to sell e-cigarettes and restric-
tions on domestic e-cigarette marketing [13,15].
E-cigarettes have attracted media attention [16].
Policymakers can be influenced by mass media coverage
of public interest stories [17] as well as public opinion
[18], and media content can demonstrably influence pub-
lic understandings and opinions [19–23]. Stakeholders
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can attempt to exert influence over public and political at-
titudes by engaging with media coverage of policy debates
[24]. Therefore, studying media debates about policy can
increase understanding of how stakeholders and their posi-
tions are represented, which can help to inform advocacy
in future debates in the United Kingdom and elsewhere.
This content analysis study examines how stakeholders’
positions on e-cigarette regulation were represented in 2
years of UK newsprint media coverage.
METHODS
A time-period of 1 January 2013 to 31 December 2014
was chosen to include the publication of the Scottish Gov-
ernment’s Tobacco Control Strategy [25] in March 2013
and the commencement of consultations on e-cigarette
regulation by the UK, Welsh [26] and Scottish Govern-
ments in late 2014 [27]. The purposive sampling frame in-
cluded eight UK and three Scottish national newspapers
from the tabloid, middle-market tabloid and quality genres
[28–30] to ensure that a diverse range of readership pro-
files was represented [31]. Each publication’s Sunday
counterpart was included, excluding the Sun on Sunday,
which is not archived in the Nexis database.
TheNexis database was searched for articles containing
three or more hits for the search term ‘e-cig OR (electronic
AND cigarette!) OR vape! OR vaping’, returning 738 arti-
cles. Each article was read and 634 were excluded on the
basis of: not mentioning e-cigarette regulation; being pub-
lished in the television review, sports, travel, weather or
readers’ letters sections of newspapers; or being a duplicate.
Following filtering, the sample comprised 104 articles.
The analytical aims were to establish: (1) how
frequently different stakeholder categories were cited; (2)
how frequently different stakeholder categories were asso-
ciated with support for, or opposition to, different forms of
e-cigarette regulation; (3) what rationales were used to jus-
tify arguments about e-cigarette regulation, and how fre-
quently; and (4) which specific regulatory positions those
corresponded with. Quantitative analysis was used to ad-
dress the first three aims, while thematic qualitative analy-
sis [32] was used to address the fourth. Each article was
double-coded by H.W. and C.P. Researchers coded over-
arching themes based on the codes assigned to the data,
discussing differences in coding and interpretation of
themes to reach consensus. Themes included the regula-
tion of minimum age of purchase, marketing, e-cigarette
use in enclosed public spaces and e-cigarettes as medicines.
To collect quantitative data, citations (either direct
quotations or indirect mentions) of stakeholders were re-
corded. Tallies were kept of: how frequently each stake-
holder was cited; how frequently they were presented
as supporting or opposing regulation in general; how fre-
quently they were presented as supporting or opposing
each specific regulatory measure; and how frequently
they were associated with specific rationales for their ar-
guments. A multi-level regression model was used to ex-
amine the rate of publication per quarter. To chart the
frequency of citations of stakeholder groups against their
stances towards regulation, an index was developed to
reflect how consistently each stakeholder category was
associated with support for regulation. The index ex-
presses the proportion of all positive and negative argu-
ments associated with a stakeholder that were in
favour of regulation as a value on a linear scale from
1 (0% supportive) to 1 (100% supportive).
RESULTS
Sample overview
The sample publications published 104 articles covering
e-cigarette regulation in 2013 (n = 28) and 2014
(n = 76), representing a mean of 4.7 articles per publica-
tion, per year (Supporting information, Table S1). Fifty-five
were published in quality genre publications, 28 in tabloids
and 21 in middle-market tabloids. Three-quarters were
published in UK publications (n= 76). Amulti-level regres-
sion model indicated that the rate of publication per quar-
ter increased over time (P < 0.001), with a peak of 33
articles in Q4 2014 (Supporting information, Figure S1).
Stakeholder categories
Stakeholders were categorized by organizational affiliation
(Table 1). The most frequently cited groups were govern-
mental and regulatory bodies (n = 50), politicians
(n = 20), health charities (n = 18) and the e-cigarette in-
dustry (n= 15). The most frequently cited individual stake-
holders were the World Health Organization (WHO,
n = 14), Scottish Government (n = 12), UK Government
(n = 10) and the health charities Action on Smoking and
Health (ASH) (n = 8) and ASH Scotland (n = 8).
Stakeholders were distributed along a continuum
ranging from strong support for, and strong opposition to,
e-cigarette regulation (Fig. 1). Governments, regulatory
bodies and bodies representing health professionals almost
uniformly supported regulation, while the smokers’ rights
group FOREST (FreedomOrganization for the Right to Enjoy
Smoking Tobacco) consistently opposed regulation, albeit in
just two citations. Politicians, health charities, manufac-
turers of e-cigarettes and academics were associated with
a range of arguments for and against e-cigarette regulation.
E-cigarette industry sources comprised independent
companies and the Electronic Cigarette Industry Trade As-
sociation (ECITA), which represents 23 e-cigarette brands
[33]. E-lites, Socialites, Vapestick and Totally Wicked were
associated with opposition to regulation, whereas JAC Va-
pour and Skycig were associated with support. ECITA was
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associated with equal proportions of arguments for and
against regulation. During the sample period, ECITA did
not represent any brands owned by transnational tobacco
companies (TTCs), and the only TTC-owned brand cited
was Skycig (then owned by RJ Reynolds American, cur-
rently owned by Imperial Tobacco under the name Blu),
which was cited as supporting age restrictions and regulat-
ing e-cigarettes as medicine.
Political parties’ stances towards regulation corres-
ponded predominantly with their political alignment,
consistent with Morley’s [34] observation that pro-tobacco
forces tend to align with the political right. Labour Party,
Green Party and Scottish National Party representatives
were presented consistently as supportive of regulation,
while Conservative Party, Liberal Democrats and UK
Independence Party (UKIP) representatives were presented
predominantly as opposed.
Stakeholders’ arguments about e-cigarette regulation
Governmental and regulatory bodies (most frequently the
WHO, Scottish Government and UK Government), health
charities (primarily ASH and ASH Scotland) and bodies
representing health professionals [primarily the British
Medical Association (BMA)] tended to support the intro-
duction of some form of regulation. Three-quarters
(n = 111) of the 146 arguments about e-cigarette regula-
tion attributed to stakeholders were in favour of regulation.
Tables 1 and 2 detail the frequency of support for, and
opposition to, specific types of regulation.
Fifty-two arguments about e-cigarette regulation were
not related to any specific measure. Specific measures that
stakeholders commented on included regulating: mini-
mum purchasing age (n = 25); marketing, advertising
and promotion (n = 25); the use of e-cigarettes in enclosed
Figure 1 Frequency of citations of stakeholder categories and their aggregate stance towards regulation (n = 104)
Table 1 Frequency of arguments for specific regulatory measures by stakeholder category.
Type of regulation
Government &
regulatory bodies
Bodies representing
health professionals
Health
charities Politicians
E-cigarette
industry Academics Total
Regulation of minimum purchasing age 11 4 4 2 4 0 25
Regulation of marketing, advertising
and promotion
16 3 3 1 0 1 24
Prohibition of e-cigarettes in enclosed
public spaces
11 4 1 1 0 0 17
Regulation of e-cigarettes as medicine 11 1 2 1 1 1 17
Prohibition of proxy purchasing 1 0 0 0 0 0 1
Total 50 12 10 5 5 2 84
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public spaces (n = 24); and e-cigarettes as medicines
(n = 19). Of the 94 statements associated with specific
measures, 84 (90.4%) were supportive and 10 (10.6%)
opposed. Supporting information, Tables S3 and S4, detail
the frequencies of stakeholder categories’ uses of different
rationales.
A minimum age for purchasing e-cigarettes was the
most frequently supported measure (n = 25), associated
frequently with child protection (n = 13). Tom Rolfe of
Skycig welcomed ‘any regulations whichwill help us to en-
sure that under-18s cannot access electronic cigarettes’
(Scotsman, 8 October 2013). Age-of-sale restrictions were
justified by framing e-cigarette use as a gateway to tobacco
use (n = 5); Mark Drakeford of the Welsh Government
highlighted the risk of ‘a new generation becoming
addicted to [nicotine]’ (Daily Mail, 3 April 2014).
Marketing regulations were supported frequently
(n = 24), and only opposed by Simon Clark of FOREST,
who argued that ‘e-cigarettes are increasingly popular
with smokers who are trying to cut down or quit [...] and
introducing greater restrictions on advertising, could do
far more harm than good’ (Scotsman, 27 June 2014).
Protecting children and young people was mentioned
frequently (n = 20) in statements advocating marketing
regulation; Deborah Arnott of ASH warned of children
being ‘targeted’ by e-cigarette marketing (Guardian, 28
April 2014).
Regulating e-cigarettes as medicine was advocated 17
times and only opposed overtly twice, by ECITA. Support
was rationalized by the need to ensure product safety and
the potential of e-cigarettes in tobacco cessation. Health
concerns related predominantly to toxicity of e-cigarette
vapour, as well as risks associated with malfunctioning e-
cigarettes and the ingestion of e-cigarette liquid. Kevin
Fenton of Public Health England described the measure
as essential to ‘assure people of their safety’ (Daily Telegraph,
26November 2014). Deborah Arnott argued that themea-
sure would ‘ensure [e-cigarettes] are good quality [...] so
they can be made available on prescription’ (Observer, 25
May 2014). Similarly, Dame Sally Davies, England’s Chief
Medical Officer, suggested that if the e-cigarette vapour con-
tent were to be controlled, e-cigarettes ‘might play a useful
role in stopping smoking’ (Daily Mail, 3 April 2014). Criti-
cism of regulating e-cigarettes as medicine highlighted the
burden on small e-cigarette manufacturers and the com-
parative benefits to TTCs. Katherine Devlin of ECITA
warned that regulationmight ‘close out all the competition
[…so TTCs…] could get the whole market share for them-
selves’ (Daily Mail, 20 May 2013).
Prohibiting e-cigarette use in enclosed public spaces
was argued for 17 times and opposed seven times. The
measure lacked the broad-ranging support across stake-
holder categories that other measures received, and was
thus the key area of disagreement between public health
stakeholders. Support for the measure was rationalized by
citing: the risks associated with exposure to second-hand
vapour; the importance of protecting children; and the risk
of re-normalizing smoking. TheWHO questioned the safety
of second-hand e-cigarette vapour: ‘the fact [e-cigarette]
exhaled aerosol contains on average lower levels of toxi-
cants than the emissions from combusted tobacco does
not mean these levels are acceptable to involuntarily ex-
posed bystanders’ (Sunday Herald, 31 August 2014). Dame
Sally Davies cautioned against ‘normalising e-cigarettes’
and ‘making smoking seem like a normal activity’ (Daily
Mail, 19 May 2014). Dr RamMoorthy of the BMAwarned
against reversing progress made towards making smoking
‘socially unacceptable’ (Sun, 22 May 2014).
Rationales used to oppose prohibiting e-cigarettes in
enclosed public spaces included their role in tobacco cessa-
tion and the limited evidence of risks. Tom Pruen of ECITA
argued that ‘being able to use [e-cigarettes] indoors is a big
incentive for people to move away from tobacco’ (Sunday
Herald, 31 August, 2014). Highlighting the limited evi-
dence base, Neil McKeganey of the Centre for Drug Misuse
Research described second-hand exposure fears as ‘theo-
retical’ (Sunday Herald, 31 August 2014), while Hazel
Cheeseman of ASH characterized ‘evidence of any harm
to bystanders from use of these devices’ (Herald, 20 August
2014) as absent.
Incomplete evidence of the health risks of e-cigarettes
was cited by stakeholders from a range of categories, and
used to support arguments both for and against regulation,
indicating that different stakeholders used the inconclusive
evidence base differently. Promoting a precautionary ap-
proach, John Middleton of the Faculty of Public Health
stated that ‘We don’t yet have enough evidence yet [sic]
of the impact [e-cigarettes] are having on other people’
Table 2 Frequency of arguments against specific regulatory measures by stakeholder category.
Health charities E-cigarette industry Smokers’ rights groups Total
Type of regulation
Prohibition of e-cigarettes in enclosed public spaces 4 2 1 7
Regulation of e-cigarettes as medicine 0 2 0 2
Regulation of marketing, advertising and promotion 0 0 1 1
Total 4 4 2 10
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(Daily Mail, 17 December 2014). Conversely, Charlie
Hamshaw-Thomas of E-Lites, advocating a harm-
reduction approach, characterized the BMA as ‘“experts”
without evidence playing puppet to the pharmaceutical
industry’s agenda’ (Scotland on Sunday, 20 October 2013).
DISCUSSION
We examined UK newsprint representations of the grow-
ing e-cigarette regulation debate, highlighting the stake-
holders involved and their stances towards regulation.
The research findings are subject to certain limitations.
As with most media analyses, the extent to which stake-
holders’ actual positions were distorted in media represen-
tations is unknown. However, given the impact of media
representations on public understandings, media represen-
tations are no less important than stakeholders’ true posi-
tions. A limitation specific to this study is that a larger
sample size, achieved by either a broader sampling frame
or longer search period, would have increased the external
validity of the findings. Further, as data on citations of
stakeholders were collected as simple tallies, we could not
investigate trends in representations of stakeholders over
time. Future research could analyse media coverage subse-
quent to 2014 to examine how representations of stake-
holders have evolved over time. Additionally, including
other forms of media, including social media, may have
added depth to understandings of the debate, particularly
as e-cigarette regulation seems to garner considerable en-
gagement online. Despite these limitations, this study
makes a valuable contribution to the literature on e-
cigarette regulation [16]. By enabling comparison between
the e-cigarette debate and other tobacco control debates,
our analysis may inform future advocacy in the United
Kingdom and internationally. We suggest that public dis-
agreement between tobacco control advocates may be
harmful to shared health policy goals. However, rather
than recommending against public debate, we would in-
stead recommend emphasizing the substantial areas of
consensus that exist.
Our data illustrate increased newspaper coverage of the
e-cigarette debate throughout 2013 and 2014, and com-
parison with data on UK newspaper coverage of other
health legislation debates indicates that the e-cigarette reg-
ulation debate occupied a similar number of articles as leg-
islation to prohibit smoking in vehicles carrying children
[35], but substantially fewer articles than proposed legisla-
tion to impose a minimum price per unit of alcohol [28].
The sharp rise in reporting on e-cigarette regulation in late
2014 suggests that the profile of the issue may have con-
tinued to rise in 2015.
We found that stakeholders supported e-cigarette reg-
ulation much more frequently than they opposed it, sug-
gesting that the overall tone of media representations of
the debate was favourable to regulation. To an extent,
this is foreseeable in a debate about potential regulation,
as the presence of arguments for regulation is a prereq-
uisite for the presence of opposing arguments.
Governments, regulatory bodies, politicians and health
charities were broadly aligned in support for regulation
of purchasing age, regulation of marketing and regulat-
ing e-cigarettes as medicine, and these measures were
rarely opposed. Widespread support for the regulation
of e-cigarettes as medicine is probably founded on a per-
ceived need to set the parameters of what e-cigarettes
and refills may be composed of, both for the protection
of consumers, as highlighted in our data, and to ensure
a uniform product for which further regulation can be
designed. Purchasing age restrictions and regulation of
marketing were frequently justified based on the need
to protect children from harm, a rationale that industry
actors have been unwilling to oppose in past tobacco
control debates [36].
Prohibition of e-cigarette use in enclosed public spaces
was the key area of disagreement within and between the
most vocal stakeholder groups. While comparable restric-
tions have been successful when applied to tobacco [37],
evidence of the risks of second-hand vaping is scarce
[38], which may go some way to explaining the relative
lack of enthusiasm for the measure. Advocates rationalized
their support primarily by citing the risks of re-normalizing
smoking behaviours, which are more abstract and perhaps
less persuasive than direct health risks. Additionally, those
positioning e-cigarettes as tobacco cessation tools
portrayed the prohibition of their use in enclosed public
spaces as counterproductive, as it would reduce tobacco
smokers’ incentives to adopt the (assumed) safer alterna-
tive. The disagreement exhibited by health charities on this
issue illustrated the challenge they face in finding balance
between the promise and threat of this disruptive
technology.
Transnational tobacco companies had a low profile in
the media debate in 2013 and 2014, indicating that TTCs’
attempted rehabilitation through engagement in harm re-
duction debates [39,40] is not evident in UK newsprint
coverage. Our data cannot explain the near-absence of
TTCs in the debate, but various explanations may be pos-
ited: TTCs may have chosen not to draw attention to their
growing share of the e-cigarette market; TTCs may be con-
fident in their financial capacity to adapt to regulation
(which could be prohibitively expensive for independent
e-cigarette companies); and TTCs may anticipate that reg-
ulation to standardize the nicotine content of e-cigarettes
will encourage profitable dual use of tobacco and e-
cigarettes. Additionally, TTCs may have decided not to
reach conclusions ahead of the EU TPD in April 2014, in
which case their profile may have risen subsequent to the
sample period.
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Tobacco control advocates have previously been unified
largely around the regulatory measures they support [41],
and coalitions and the promotion of unambiguous mes-
sages have been instrumental to successful advocacy
[42,43]. Our analysis found that public health stakeholders
demonstrated less unity in the e-cigarette regulation de-
bate than in previous tobacco control debates [41], and
the two open letters addressed to the WHO by opposing
groups of public health and medical experts [41] indicate
that that disunity exists beyond media representations.
The first letter advised the WHO to recognize the harm re-
duction potential of e-cigarettes and reverse recommenda-
tions for regulation that would suppress their availability,
while the second supported the WHO’s existing precau-
tionary stance on e-cigarette regulation. Disagreement be-
tween public health stakeholders may be explained
partially by the absence (prior to October 2014) of official
international guidance on the issue, as WHO guidance
has been found to have aided consensus-building in past to-
bacco control advocacy [43–46]. Variations in stake-
holders’ positions might also be explained by the
incomplete evidence base concerning the harms and
benefits of e-cigarettes, differing starkly from the compre-
hensive evidence for the harms of tobacco.
Rather than solely attributing disagreements to limited
evidence, we suggest that more fundamental barriers to
agreement lie in the frameworks within which actors inter-
pret and use that evidence base. Fairchild & Bayer [4] argue
that differing assessments of e-cigarettes stem from conflict-
ing philosophical frameworks of public health: harm reduc-
tion and precaution. Harm reduction can be described as a
pragmatic approach acknowledging that people will inevita-
bly use drugs, and viewing risk minimization as a worthy
public health goal, whereas precautionary approaches
focus on the complete elimination of harmful habits, argu-
ing that simply reducing harm is undesirable and cautioning
against serving the interests of TTCs. The same evidence
may be interpreted differently depending on the framework
that is applied. Our analysis indicates that stakeholders
using rationales commensurate with harm reduction (such
as promoting e-cigarettes as tobacco cessation aids or
highlighting the lack of evidence of the risks of e-cigarettes)
tended to oppose the prohibition of e-cigarette use in
enclosed public spaces, while those using precautionary
rationales (such as cautioning against the re-normalization
of smoking and the potential role of e-cigarettes as gateways
to tobacco) tended to favour comprehensive regulation.
Stakeholders may model their stances towards regulation
based on their pre-existing adherence to a specific frame-
work, but equally these frameworks may be used to post-
rationalize stances towards regulation.
Divisions between public health stakeholders exist
within other tobacco control debates [47]. For example,
some forms of smokeless tobacco are promoted as tobacco
cessation aids by some [48] and cautioned against by
others, who highlight their carcinogenic content, the in-
volvement of TTCs in their production and marketing and
the inconclusive evidence of their effectiveness in tobacco
cessation [49]. Given that conflict within the tobacco con-
trol community is neither a new phenomenon nor one that
relates exclusively to e-cigarettes, confronting disagree-
ment is of relevance beyond the e-cigarette regulation de-
bate. Industry actors with a history of opposing tobacco
control legislation could exploit disagreement by character-
izing tobacco control regulation as contested. This threat
may incentivize public health advocates to develop com-
mon ground further and highlight existing agreement to
present unified, unambiguous positions.
This paper contributes to the body of literature
concerning mass media representations of public health
policy and the dynamics of e-cigarette regulation debates.
While public health stakeholders are largely unified in sup-
port of e-cigarette regulation, the disagreement that exists,
concerning primarily the regulation of e-cigarettes in pub-
lic places, is evident in the public sphere. Given the persua-
sive power of presenting consistent messages in tobacco
control debates, achieving consensus and agreeing on un-
ambiguous advocacy positions on e-cigarette regulation
would probably increase the political effectiveness of the
public health community. As public health stakeholders
draw from divergent frameworks, reaching consensus is
not simply a case of awaiting further research evidence,
but one of negotiating shared values concerning how evi-
dence is interpreted and presented. If critical engagement
with public health frameworks is impractical, then a more
pragmatic goal for the tobacco control community may be
to refrain from commenting on contentious aspects of reg-
ulation in the public sphere to avoid giftingopponents of to-
bacco control the opportunity to exploit uncertainty, and
focus instead on common areas of agreement. Ongoing de-
bates about e-cigarette regulation and other tobacco con-
trol issues in the United Kingdom and abroad may benefit
from incorporating this approach.
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